BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2575396)

  • 1. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
    Mills KH; Nixon DF; McMichael AJ
    AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396
    [No Abstract]   [Full Text] [Related]  

  • 2. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV immunization. Fresh pathways to follow.
    Bolognesi DP
    Nature; 1990 Apr; 344(6269):818-9. PubMed ID: 1691822
    [No Abstract]   [Full Text] [Related]  

  • 4. [Repertoire of epitopes of human immunodeficiency virus proteins and the search for vaccines and diagnostic kits].
    Kharchenko EP; Klimenko AP
    Dokl Akad Nauk SSSR; 1992; 322(1):189-92. PubMed ID: 1380907
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro selection of HIV and CMV specific T-lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
    J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lucky ones. How do some HIV-positive people avoid getting AIDS?
    Beardsley T
    Sci Am; 1994 May; 270(5):20, 24, 28. PubMed ID: 7910979
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS.
    Wasik TJ; Wierzbicki A; Whiteman VE; Trinchieri G; Lischner HW; Kozbor D
    Eur J Immunol; 2000 Jan; 30(1):117-27. PubMed ID: 10602033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS: an autoimmune pathologic model for the destruction of a subset of helper T lymphocytes.
    Shearer GM
    Mt Sinai J Med; 1986 Dec; 53(8):609-15. PubMed ID: 2949147
    [No Abstract]   [Full Text] [Related]  

  • 11. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.
    Stricker RB; McHugh TM; Moody DJ; Morrow WJ; Stites DP; Shuman MA; Levy JA
    Nature; 1987 Jun 25-Jul 1; 327(6124):710-3. PubMed ID: 2955226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunopathogenesis and therapeutic approaches in acquired immunologic deficiency syndrome (AIDS)].
    Zielinski C
    Acta Med Austriaca; 1987; 14(1):5-9. PubMed ID: 2956821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of cytotoxic T cell responses].
    Autran B
    Ann Rech Vet; 1992; 23(3):301-4. PubMed ID: 1384418
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
    Zinkernagel RM; Hengartner H
    Immunol Today; 1994 Jun; 15(6):262-8. PubMed ID: 7915115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper T-cell type 1 or type 2 function of xeno-MHC-restricted T-cell clones in a direct xenoantigen recognition.
    Iida Y; Iwata H; Mori Y; Takagi H; Nitta T; Kanetake K; Umeda Y; Hirose H
    Transpl Immunol; 2003; 11(2):169-73. PubMed ID: 12799200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-specific cytotoxic T lymphocytes and their possible implications in the future vaccine against AIDS.
    Langlade-Demoyen P; Hoffenbach A
    Res Immunol; 1989 Jan; 140(1):95-9; discussion 119-20. PubMed ID: 2567045
    [No Abstract]   [Full Text] [Related]  

  • 19. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
    J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
    J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.